These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 17939258

  • 21. Resistance to UV-induced cell-killing in nucleophosmin/B23 over-expressed NIH 3T3 fibroblasts: enhancement of DNA repair and up-regulation of PCNA in association with nucleophosmin/B23 over-expression.
    Wu MH, Chang JH, Yung BY.
    Carcinogenesis; 2002 Jan; 23(1):93-100. PubMed ID: 11756229
    [Abstract] [Full Text] [Related]

  • 22. Oncogene-dependent tumor suppression: using the dark side of the force for cancer therapy.
    Evan GI, Christophorou M, Lawlor EA, Ringshausen I, Prescott J, Dansen T, Finch A, Martins C, Murphy D.
    Cold Spring Harb Symp Quant Biol; 2005 Jan; 70():263-73. PubMed ID: 16869762
    [Abstract] [Full Text] [Related]

  • 23. [Isolation of the protein B23/nucleophosmin from HeLa cell nuclei].
    Sautkina EN, Potapenko NA, Bulycheva TI, Vladimirova NM.
    Prikl Biokhim Mikrobiol; 2008 Jan; 44(3):287-95. PubMed ID: 18663951
    [Abstract] [Full Text] [Related]

  • 24. Nucleophosmin/B23 regulates the susceptibility of human leukemia HL-60 cells to sodium butyrate-induced apoptosis and inhibition of telomerase activity.
    Liu WH, Hsu CY, Yung BY.
    Int J Cancer; 1999 Dec 10; 83(6):765-71. PubMed ID: 10597193
    [Abstract] [Full Text] [Related]

  • 25. The role of nucleophosmin/B23 in radiation-induced chromosomal instability in human lymphoblastoid cells of different p53 genotypes.
    Chen H, Jia R, Zhou M, Xu A, Hu Y, Cheng W, Shao C.
    Int J Radiat Biol; 2010 Dec 10; 86(12):1031-43. PubMed ID: 20807181
    [Abstract] [Full Text] [Related]

  • 26. Nucleophosmin/B23, a nuclear PI(3,4,5)P(3) receptor, mediates the antiapoptotic actions of NGF by inhibiting CAD.
    Ahn JY, Liu X, Cheng D, Peng J, Chan PK, Wade PA, Ye K.
    Mol Cell; 2005 May 13; 18(4):435-45. PubMed ID: 15893727
    [Abstract] [Full Text] [Related]

  • 27. [Analysis of the proliferative activity of a cell using new monoclonal antibodies to nucleolar protein B23/nucleophosmin].
    Bulycheva TI, Dergunova NN, Artemenko EG, Dudnik OA, Shpakova AP, Malashenko OS, Zatsepina OV.
    Tsitologiia; 2000 May 13; 42(10):944-54. PubMed ID: 11200134
    [Abstract] [Full Text] [Related]

  • 28. Role of nucleophosmin in acute myeloid leukemia.
    Meani N, Alcalay M.
    Expert Rev Anticancer Ther; 2009 Sep 13; 9(9):1283-94. PubMed ID: 19761432
    [Abstract] [Full Text] [Related]

  • 29. Overexpression of the nucleolar protein nucleophosmin/B23 in collagen lattice-cultured fibroblasts: potential role in the control of protein synthesis.
    Lefèvre F, Garnotel R, Georges N, Gillery P.
    Mol Cell Biochem; 2002 Jan 13; 229(1-2):45-50. PubMed ID: 11936846
    [Abstract] [Full Text] [Related]

  • 30. HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism.
    Mottet D, Pirotte S, Lamour V, Hagedorn M, Javerzat S, Bikfalvi A, Bellahcène A, Verdin E, Castronovo V.
    Oncogene; 2009 Jan 15; 28(2):243-56. PubMed ID: 18850004
    [Abstract] [Full Text] [Related]

  • 31. E2F1 in gliomas: a paradigm of oncogene addiction.
    Alonso MM, Alemany R, Fueyo J, Gomez-Manzano C.
    Cancer Lett; 2008 May 18; 263(2):157-63. PubMed ID: 18334281
    [Abstract] [Full Text] [Related]

  • 32. Increased stability of nucleophosmin/B23 in anti-apoptotic effect of ras during serum deprivation.
    Chou CC, Yung BY.
    Mol Pharmacol; 2001 Jan 18; 59(1):38-45. PubMed ID: 11125022
    [Abstract] [Full Text] [Related]

  • 33. PI3K signaling maintains c-myc expression to regulate transcription of E2F1 in pancreatic cancer cells.
    Schild C, Wirth M, Reichert M, Schmid RM, Saur D, Schneider G.
    Mol Carcinog; 2009 Dec 18; 48(12):1149-58. PubMed ID: 19603422
    [Abstract] [Full Text] [Related]

  • 34. Berberine-induced apoptosis of human leukemia HL-60 cells is associated with down-regulation of nucleophosmin/B23 and telomerase activity.
    Wu HL, Hsu CY, Liu WH, Yung BY.
    Int J Cancer; 1999 Jun 11; 81(6):923-9. PubMed ID: 10362140
    [Abstract] [Full Text] [Related]

  • 35. Over-expression of nucleophosmin/B23 decreases the susceptibility of human leukemia HL-60 cells to retinoic acid-induced differentiation and apoptosis.
    Hsu CY, Yung BY.
    Int J Cancer; 2000 Nov 01; 88(3):392-400. PubMed ID: 11054668
    [Abstract] [Full Text] [Related]

  • 36. Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4-216) recognizes nucleophosmin/B23.
    Subong EN, Shue MJ, Epstein JI, Briggman JV, Chan PK, Partin AW.
    Prostate; 1999 Jun 01; 39(4):298-304. PubMed ID: 10344220
    [Abstract] [Full Text] [Related]

  • 37. Nucleophosmin, HDM2 and p53: players in UV damage incited nucleolar stress response.
    Kurki S, Peltonen K, Laiho M.
    Cell Cycle; 2004 Aug 01; 3(8):976-9. PubMed ID: 15254398
    [Abstract] [Full Text] [Related]

  • 38. Influence of nucleophosmin/B23 on DNA binding and transcriptional activity of the androgen receptor in prostate cancer cell.
    Léotoing L, Meunier L, Manin M, Mauduit C, Decaussin M, Verrijdt G, Claessens F, Benahmed M, Veyssière G, Morel L, Beaudoin C.
    Oncogene; 2008 May 01; 27(20):2858-67. PubMed ID: 18037965
    [Abstract] [Full Text] [Related]

  • 39. Tumor suppressor SMAR1 downregulates Cytokeratin 8 expression by displacing p53 from its cognate site.
    Pavithra L, Singh S, Sreenath K, Chattopadhyay S.
    Int J Biochem Cell Biol; 2009 Apr 01; 41(4):862-71. PubMed ID: 18822384
    [Abstract] [Full Text] [Related]

  • 40. Nucleophosmin/B23 promotes endometrial cancer cell escape from macrophage phagocytosis by increasing CD24 expression.
    Lin CY, Tsai CL, Chao A, Lee LY, Chen WC, Tang YH, Chao AS, Lai CH.
    J Mol Med (Berl); 2021 Aug 01; 99(8):1125-1137. PubMed ID: 33954835
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.